News of Note—APAC adds 50 jobs at Virginia site; New sterile injectable CMO forms

stock market
(Pixabay)

 

> China's WuXi Biologics says it is adding commercial manufacturing to the integrated biologics conjugation solution center it is building in Wuxi, China. Release

> Two U.K. contract manufacturers, Cobra Biologics and Symbiosis Pharmaceutical Services, have invested £4.8 million in a collaboration on viral vector manufacturing. Release 

> After making upgrades, API maker AMPAC Fine Chemicals has reopened a plant in Petersburg, Virginia, that has a 50,000-gallon capacity and will add 150 jobs. Release 

Conference

The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

> A new CMO has come on the scene with plans to build a $30 million sterile drug manufacturing facility on the West Coast. Story

Read more on

Suggested Articles

Novartis' AveXis will use Catalent for some manufacturing of its newly approved gene therapy Zolgensma and more manufacturing news of note.

Pharmacy chain Rite Aid has partnered with Google to have their drug recycling stations easily searchable on Google Maps. 

Precision BioSciences says it will have a manufacturing facility for its off-the-shelf CAR-T therapies up and running in the fourth quarter.